{"id":62491,"date":"2026-02-24T11:01:37","date_gmt":"2026-02-24T05:31:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=62491"},"modified":"2026-02-24T11:02:02","modified_gmt":"2026-02-24T05:32:02","slug":"gaudium-ivf-women-health-ipo-gmp-subscription-day-3","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/","title":{"rendered":"Gaudium IVF &#038; Women Health IPO Day 3: Subscription at 1.62x, GMP Rises 6.33% | Live Updates"},"content":{"rendered":"<p>The <strong>Gaudium IVF &amp; Women Health IPO GMP <\/strong>is \u20b97.5 as of 24th February 2026. It is a book-building issue IPO of \u20b9165.00 crores. This is an entirely fresh issue of 1.14 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 27th February 2026. The face value of Gaudium IVF &amp; Women Health IPO shares is \u20b910 per share, and the IPO price band is \u20b975 to \u20b979 per share. Retail investors can bid for a minimum of 1 lot of 189 shares worth \u20b914,931. Scroll down to check the Gaudium IVF &amp; Women Health IPO GMP and subscription details.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Women_Health_IPO_GMP_Grey_Market_Premium\" title=\"Gaudium IVF &amp; Women Health IPO GMP Grey Market Premium\">Gaudium IVF &amp; Women Health IPO GMP Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Womens_Health_IPO_Subscription_Status\" title=\"Gaudium IVF &amp; Women&#8217;s Health IPO Subscription Status\">Gaudium IVF &amp; Women&#8217;s Health IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Women_Health_IPO_Details\" title=\"Gaudium IVF &amp; Women Health IPO Details\">Gaudium IVF &amp; Women Health IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#About_Gaudium_IVF_Womens_Health_Ltd\" title=\"About Gaudium IVF &amp; Women&#8217;s Health Ltd.\">About Gaudium IVF &amp; Women&#8217;s Health Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Women_Health_Limited_Financials\" title=\"Gaudium IVF &amp; Women Health Limited Financials\">Gaudium IVF &amp; Women Health Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Explanation-2\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Womens_Health_IPO_Objectives\" title=\"Gaudium IVF &amp; Women&#8217;s Health IPO Objectives\">Gaudium IVF &amp; Women&#8217;s Health IPO Objectives<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Womens_Health_IPO_Registrar\" title=\"Gaudium IVF &amp; Women&#8217;s Health IPO Registrar\">Gaudium IVF &amp; Women&#8217;s Health IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Gaudium_IVF_Womens_Health_IPO_Review\" title=\"Gaudium IVF &amp; Women&#8217;s Health IPO Review\">Gaudium IVF &amp; Women&#8217;s Health IPO Review<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#FAQs_on_Gaudium_IVF_Womens_Health_IPO\" title=\"FAQs on Gaudium IVF &amp; Women&#8217;s Health IPO\">FAQs on Gaudium IVF &amp; Women&#8217;s Health IPO<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#What_is_the_Gaudium_IVF_Womens_Health_IPO_GMP\" title=\"What is the Gaudium IVF &amp; Women&#8217;s Health IPO GMP?\">What is the Gaudium IVF &amp; Women&#8217;s Health IPO GMP?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#What_is_the_issue_price_of_the_Gaudium_IVF_Womens_Health_IPO\" title=\"What is the issue price of the Gaudium IVF &amp; Women&#8217;s Health IPO?\">What is the issue price of the Gaudium IVF &amp; Women&#8217;s Health IPO?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Who_is_the_registrar_of_the_Gaudium_IVF_Women_Health_IPO\" title=\"Who is the registrar of the Gaudium IVF &amp; Women Health IPO?\">Who is the registrar of the Gaudium IVF &amp; Women Health IPO?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-women-health-ipo-gmp-subscription-day-3\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Women_Health_IPO_GMP_Grey_Market_Premium\"><\/span><strong>Gaudium IVF &amp; Women Health IPO GMP Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As mentioned earlier, the <strong>Gaudium IVF &amp; Women Health IPO GMP <\/strong>currently stands at \u20b97.5 per share. Thus, the estimated listing price would be at \u20b984.00. This indicates that the estimated listing gain in this IPO could be 6.33%. Explore the table for <strong>Gaudium IVF &amp; Women Health<\/strong> <strong>IPO GMP<\/strong> updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP DATE<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP Price<\/strong><\/td><td><strong>Estimated Listing Price<\/strong><\/td><td><strong>Estimated Gain<\/strong><\/td><\/tr><tr><td><strong>24-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b95.00<\/td><td>\u20b984.00<\/td><td>6.33%<\/td><\/tr><tr><td><strong>23-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b95.00<\/td><td>\u20b984.00<\/td><td>6.33%<\/td><\/tr><tr><td><strong>22-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b98.5<\/td><td>\u20b987.5<\/td><td>10.76%<\/td><\/tr><tr><td><strong>21-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b98.5<\/td><td>\u20b987.5<\/td><td>10.76%<\/td><\/tr><tr><td><strong>20-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b98.00<\/td><td>\u20b987.00<\/td><td>10.13%<\/td><\/tr><tr><td><strong>19-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b98.5<\/td><td>\u20b987.5<\/td><td>10.76%<\/td><\/tr><tr><td><strong>18-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b912.00<\/td><td>\u20b991.00<\/td><td>15.19%<\/td><\/tr><tr><td><strong>17-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b915.00<\/td><td>\u20b994.00<\/td><td>18.99%<\/td><\/tr><tr><td><strong>16-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b90.00<\/td><td>\u20b979.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>15-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b90.00<\/td><td>\u20b979.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>14-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b90.00<\/td><td>\u20b979.00<\/td><td>0.00%<\/td><\/tr><tr><td><strong>13-2-2026<\/strong><\/td><td>\u20b979.00<\/td><td>\u20b90.00<\/td><td>\u20b979.00<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><p><em>Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Gaudium IVF &amp; Women Health IPO GMP status at Univest.<\/em><\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Gaudium IVF &amp; Women Health IPO <\/em><\/strong><strong>GMP Status<\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Womens_Health_IPO_Subscription_Status\"><\/span><strong>Gaudium IVF &amp; Women&#8217;s Health IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of now, the Gaudium IVF &amp; Women Health IPO has been subscribed to 3.59 times. Of these, 4.58 times are subscribed by retail investors, 6.05 times by non-institutional investors, and 0.03 times by QII (Qualified Institutional Investors).&nbsp;&nbsp;<\/p><p>The healthy subscription status indicates that investors are expecting higher returns at the time of Gaudium IVF &amp; Women&#8217;s Health&#8217;s IPO listing on 27th February 2026. Gaudium IVF &amp; Women Health also has a positive outlook behind the fresh issue of 1.14 crore shares, which will raise around Rs 165.00 crores.<\/p><p><strong><em>Note:<\/em><\/strong><em> GMP details are subject to change based on market conditions and fluctuations. Check the live Gaudium IVF &amp; Women&#8217;s Health IPO Subscription status at Univest.<\/em><\/p><p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Live Updates on Gaudium IVF &amp; Women&#8217;s Health IPO Subscription<\/em><\/strong><strong> Status<\/strong><\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Women_Health_IPO_Details\"><\/span><strong>Gaudium IVF &amp; Women Health IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>25th February 2026<\/td><\/tr><tr><td><strong>IPO Open Date<\/strong><\/td><td>20th January 2026<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>24th February 2026<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>25th February 2026<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>2,08,86,200 shares(agg. up to \u20b9165 Cr)<\/td><\/tr><tr><td><strong>Fresh Issue<\/strong><\/td><td>1,13,92,500 shares(agg. up to \u20b990 Cr)<\/td><\/tr><tr><td><strong>Offer for Sale&nbsp;<\/strong><\/td><td>94,93,700 shares of \u20b95(agg. up to \u20b975 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b95 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>189 Shares<\/td><\/tr><tr><td><strong>Issue Price&nbsp;<\/strong><\/td><td>\u20b975 to \u20b979 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE NSE<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>27th February 2026<\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Also Read: <\/em><\/strong><a href=\"https:\/\/univest.in\/blogs\/gaudium-ivf-women-health-ipo-review\"><strong><em>Gaudium IVF &amp; Women Health IPO GMP &amp; Review: Apply or Avoid?<\/em><\/strong><\/a><\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Gaudium IVF &amp; Women Health IPO<\/strong>: Gaudium IVF &amp; Women Health IPO Limited has declared an issue price band of \u20b975 to \u20b979 per share. With this IPO, the company allows retail investors to bid for at least 1 lots of 189 shares, each worth \u20b914,931. The face value of Gaudium IVF &amp; Women Health IPO Limited shares is \u20b95 per share. The shares of Gaudium IVF &amp; Women Health IPO Limited will be listed on BSE and NSE on its tentative listing day, 27th February 2026. Scroll down to check GMP updates and <strong>Gaudium IVF &amp; Women Health IPO <\/strong>reviews.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Gaudium_IVF_Womens_Health_Ltd\"><\/span><strong>About Gaudium IVF &amp; Women&#8217;s Health Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Gaudium IVF &amp; Women Health Incorporated in March 2015, Gaudium IVF and Women Health Limited have been involved in In Vitro Fertilisation (IVF) procedures across India and have extended their services to several states using a hub-and-spoke model of operation. The firm has more than thirty locations, consisting of seven hubs (centres) and twenty-eight spokes. The firm has formed a strategic alliance with Infertility Experts, referred to as Spokes, to attain the common goal of creating awareness about Assisted Reproductive Technology (ART) and In Vitro Fertilisation (IVF) procedures. The firm provides services to patients belonging to different nations, such as Canada, the United Kingdom, the United States of America, Kenya, South Africa, and Oman.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Women_Health_Limited_Financials\"><\/span><strong>Gaudium IVF &amp; Women Health Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for the<strong> Gaudium IVF &amp; Women Health IPO. <\/strong>See the table for Gaudium IVF &amp; Women Health Limited&#8217;s financials.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th Sep 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>106.62<\/td><td>88.51<\/td><td>51.01<\/td><td>36.63<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>49.75<\/td><td>70.96<\/td><td>48.15<\/td><td>44.26<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>12.51<\/td><td>19.13<\/td><td>10.32<\/td><td>13.53<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>18.95<\/td><td>28.63<\/td><td>19.27<\/td><td>20.07<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>58.85<\/td><td>46.30<\/td><td>26.99<\/td><td>22.73<\/td><\/tr><tr><td><strong>Reserves and Surplus<\/strong><\/td><td>28.16<\/td><td>15.60<\/td><td>26.00<\/td><td>21.74<\/td><\/tr><tr><td><strong>Total Borrowings<\/strong><\/td><td>22.51<\/td><td>18.93<\/td><td>15.73<\/td><td>9.78<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation-2\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Gaudium IVF &amp; Women Health Limited&#8217;s revenue increased by 47.37% from \u20b948.15 crores in March 2024 to \u20b970.96 crores in March 2025. Moreover, the company&#8217;s PAT increased by 85.36% from \u20b910.32 crores in March 2024 to \u20b919.13 crores in March 2025.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Womens_Health_IPO_Objectives\"><\/span><strong>Gaudium IVF &amp; Women&#8217;s Health IPO Objectives<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Gaudium IVF &amp; Women&#8217;s Health IPO<\/strong> is to raise \u20b9165.00 crores. On the other hand, Fractal Analytics has decided to utilise these funds in different ways.<\/p><ul class=\"wp-block-list\"><li>To fund capital expenditure towards the establishment of the New IVF Centres of the Company.<\/li>\n\n<li>To General Corporate Purposes<\/li>\n\n<li>To Repayment\/pre-payment, in full or in part, of certain outstanding loans availed by the Company.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Womens_Health_IPO_Registrar\"><\/span><strong>Gaudium IVF &amp; Women&#8217;s Health IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Bigshare Services Private Limited is the registrar for the Gaudium IVF &amp; Women&#8217;s Health IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Gaudium IVF &amp; Women Health allotment and refund, you can contact Bigshare Services Private Limited at <a href=\"mailto:ipo@bigshareonline.com\">ipo@bigshareonline.com<\/a> or at +91-22-6263 8200.<\/p><p><strong><em>Download the <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong>&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Gaudium_IVF_Womens_Health_IPO_Review\"><\/span><strong>Gaudium IVF &amp; Women&#8217;s Health IPO Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-1024x536.jpg\" alt=\"Gaudium IVF &amp; Women's Health IPO Review\n\" class=\"wp-image-62493\" srcset=\"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-1024x536.jpg 1024w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-300x157.jpg 300w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-768x402.jpg 768w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-900x471.jpg 900w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-600x314.jpg 600w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-150x79.jpg 150w, https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure><p>The <strong>Gaudium IVF &amp; Women&#8217;s Health IPO <\/strong>has gained neutral ratings from industry experts, brokers, and institutional investors. Gaudium IVF &amp; Women Health Limited&#8217;s revenue increased by 47.37% from \u20b948.15 crores in March 2024 to \u20b970.96 crores in March 2025. Moreover, the company&#8217;s PAT increased by 85.36% from \u20b910.32 crores in March 2024 to \u20b919.13 crores in March 2025. Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we\u2019re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for the <strong>Gaudium IVF &amp; Women&#8217;s Health IPO <\/strong>or not.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>25.36<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>3.12<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>21.34%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>21.03%<\/td><\/tr><tr><td><strong>ROE<\/strong><\/td><td>21.25%<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>38.29%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>&#8211;<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b9575.02 Cr<\/td><\/tr><\/tbody><\/table><\/figure><p>The P\/E ratio of Gaudium IVF &amp; Women Health Limited shares is 25.36, and its Earnings Per Share (EPS) stands at 3.12. Thus, the <strong>Gaudium IVF &amp; Women Health IPO<\/strong> can deliver gains on its tentative listing date, 27th February 2026.&nbsp;<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Gaudium IVF &amp; Women&#8217;s Health Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><strong>PE Ratio<\/strong><\/td><td>25.36<\/td><td>22.99<\/td><\/tr><tr><td><strong>EPS&nbsp;<\/strong><\/td><td>3.12<\/td><td>3.44<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Gaudium_IVF_Womens_Health_IPO\"><\/span><strong>FAQs on Gaudium IVF &amp; Women&#8217;s Health IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_Gaudium_IVF_Womens_Health_IPO_GMP\"><\/span><strong>What is the Gaudium IVF &amp; Women&#8217;s Health IPO GMP?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Currently, on 24th February 2026, the <strong>Gaudium IVF &amp; Women Health IPO GMP<\/strong> (Grey Market Premium) stands at \u20b95. This indicates that the estimated listing price could be \u20b984 per share.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_is_the_issue_price_of_the_Gaudium_IVF_Womens_Health_IPO\"><\/span><strong>What is the issue price of the Gaudium IVF &amp; Women&#8217;s Health IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>The Gaudium IVF &amp; Women Health IPO issue price band is set at \u20b975.00 to \u20b979.00 per share. Retail investors can apply for a minimum of 1 lots, each consisting of 189 shares, worth \u20b914,931. Moreover, HNIs are required to bid for a minimum of 14 lots (189 shares) worth \u20b914,931.<\/p><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Who_is_the_registrar_of_the_Gaudium_IVF_Women_Health_IPO\"><\/span><strong>Who is the registrar of the Gaudium IVF &amp; Women Health IPO?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Bigshare Services Private Limited is the registrar for the Gaudium IVF &amp; Women Health IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Gaudium IVF &amp; Women Health allotment and refund, you can contact Bigshare Services Private Limited at ipo@bigshareonline.com or at +91-22-6263 8200.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Gaudium IVF &amp; Women Health IPO, download the Gaudium IVF &amp; Women Health IPO RHP and Gaudium IVF &amp; Women Health IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/yashhtej-industries-ipo-gmp-subscription-day-3\">Yashhtej Industries IPO Day 3: Subscription at 0.92x, GMP Rises 10.91% | Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/gaudium-ivf-women-health-ipo-gmp-subscription-day-1\">Gaudium IVF &amp; Women Health IPO Day 1: Subscription at 0.27x, GMP Rises 10.76% | Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/manilam-industries-ipo-gmp-subscription-day-1\">Manilam Industries IPO Day 1: Subscription at 0.03x, GMP Flat | Live Updates<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/yashhtej-industries-ipo-allotment-status\">Yashhtej Industries IPO Allotment Status: 1.05x Subscribed, GMP Rises 1.82% \u2014 Check Online<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/pngs-reva-diamond-jewellery-ipo-review\">PNGS Reva Diamond Jewellery IPO Review 2026: GMP Rises 5.70%, Key Investor Insights<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The Gaudium IVF &amp; Women Health IPO GMP is \u20b97.5 as of 24th February 2026. It is a book-building issue IPO of \u20b9165.00 crores. This is an entirely fresh issue of 1.14 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 27th February 2026. The face value of<\/p>\n","protected":false},"author":28,"featured_media":62494,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[1015,1352,3806],"class_list":["post-62491","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-ipo","tag-ipo-gmp","tag-ipo-subscription"],"metadata":{"_edit_lock":["1771911126:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"amazonS3_cache":["a:4:{s:97:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/02\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1.jpg\";a:2:{s:2:\"id\";i:62493;s:11:\"source_type\";s:13:\"media-library\";}s:106:\"\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/02\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-1024x536.jpg\";a:2:{s:2:\"id\";i:62493;s:11:\"source_type\";s:13:\"media-library\";}s:129:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1.jpg\";a:2:{s:2:\"id\";i:62493;s:11:\"source_type\";s:13:\"media-library\";}s:138:\"\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105606\/Gaudium-IVF-Women-Health-IPO-Apply-or-Avoid-1-1024x536.jpg\";a:2:{s:2:\"id\";i:62493;s:11:\"source_type\";s:13:\"media-library\";}}"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["74"],"rank_math_title":["Gaudium IVF &amp; Women Health IPO Day 3: 1.62x Subscribed, GMP Rises 6.33%"],"rank_math_description":["Gaudium IVF &amp; Women Health IPO Day 3 sees weak demand at just 1.62x subscription, even as GMP rises 6.33%. Check the latest subscription and grey-market updates. Read more!\n"],"rank_math_focus_keyword":["Gaudium IVF & Women Health IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["62494"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["6585"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/02\/24105656\/Gaudium-IVF-Women-Health-IPO-GMP-Subscription-Status-Day-3.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/62491","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=62491"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/62491\/revisions"}],"predecessor-version":[{"id":62495,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/62491\/revisions\/62495"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/62494"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=62491"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=62491"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=62491"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}